Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from IR-Med ( (IRME) ) is now available.
On June 5, 2025, IR-Med, Inc. entered into a Securities Purchase Agreement with certain investors to issue and sell 591,187 shares of common stock in a private placement offering, which closed on June 9, 2024, for gross proceeds of $88,678. The transaction was exempt from registration under the Securities Act, and the securities cannot be sold in the U.S. without registration or an exemption, impacting the company’s financial positioning and investor relations.
More about IR-Med
IR-Med, Inc. operates in the medical technology industry, focusing on the development and commercialization of innovative medical devices and solutions.
Average Trading Volume: 54,930
Technical Sentiment Signal: Sell
Current Market Cap: $5.76M
For an in-depth examination of IRME stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue